COST-EFFECTIVENESS OF POST-TREATMENT FOLLOW-UP AND SECONDARY PREVENTION OF TUBERCULOSIS IN A HIGH-INCIDENCE SETTING - A MODEL-BASED ANALYSIS

被引：0
|
作者：
Marx, Florian [1 ]
Cohen, Ted [2 ]
Menzies, Nicolas [3 ]
Salomon, Joshua [4 ,5 ]
Yaesoubi, Reza [2 ]
机构：
[1] DST NRF South African Ctr Excellence Epidemiol M, Stellenbosch, South Africa
[2] Yale Sch Publ Hlth, New Haven, CT USA
[3] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA
[4] Ctr Hlth Policy, Stanford, CA USA
[5] Ctr Primary Care & Outcomes Res, Stanford, CA USA
来源：
MEDICAL DECISION MAKING | 2020年 / 40卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
5N-6
引用
收藏
页码：E360 / E361
页数：2
相关论文
共 50 条
  • [31] THE COST-EFFECTIVENESS OF COMBINED VECTOR-CONTROL AND VACCINATION STRATEGIES ON PREVENTION OF DENGUE FEVER: A DYNAMIC MODEL-BASED ANALYSIS
    Knerer, G.
    Currie, C.
    Brailsford, S.
    VALUE IN HEALTH, 2014, 17 (07) : A806 - A806
  • [32] Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis
    Kathryn Schnippel
    Cynthia Firnhaber
    Francesca Conradie
    Norbert Ndjeka
    Edina Sinanovic
    Applied Health Economics and Health Policy, 2018, 16 : 43 - 54
  • [33] Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis
    Schnippel, Kathryn
    Firnhaber, Cynthia
    Conradie, Francesca
    Ndjeka, Norbert
    Sinanovic, Edina
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (01) : 43 - 54
  • [34] Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data
    Bischof, Matthias
    Briel, Matthias
    Bucher, Heiner C.
    Nordmann, Alain
    VALUE IN HEALTH, 2009, 12 (05) : 649 - 656
  • [35] Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed US regulatory relaxations: A model-based analysis
    Qian, Gary
    Humphreys, Keith
    Goldhaber-Fiebert, Jeremy D.
    Brandeau, Margaret L.
    DRUG AND ALCOHOL DEPENDENCE, 2024, 256
  • [36] Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis
    Hamers, Raph L.
    Sawyer, A. W.
    Tuohy, Martin
    Stevens, Wendy S.
    de Wit, Tobias F. Rinke
    Hill, Andrew M.
    AIDS, 2012, 26 (13) : 1663 - 1672
  • [37] Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms: A Markov Model-Based Cost-Effectiveness Analysis
    Rink, Johann S.
    Froelich, Matthias F.
    McWilliams, Justin P.
    Gratzke, Christian
    Huber, Thomas
    Gresser, Eva
    Schoenberg, Stefan O.
    Diehl, Steffen J.
    Noerenberg, Dominik
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2022, 19 (06) : 733 - 743
  • [38] Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial
    Dedes, K. J.
    Szucs, T. D.
    Imesch, P.
    Fedier, A.
    Fehr, M. K.
    Fink, D.
    ANNALS OF ONCOLOGY, 2007, 18 (09) : 1493 - 1499
  • [39] Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods
    Bozzani, Fiammetta Maria
    McCreesh, Nicky
    Diaconu, Karin
    Govender, Indira
    White, Richard G.
    Kielmann, Karina
    Grant, Alison D.
    Vassall, Anna
    BMJ GLOBAL HEALTH, 2023, 8 (02):
  • [40] Cost-Effectiveness of Episodic or Maintenance Infliximab Treatment Versus Standard Treatment in a Community-Based Incidence Cohort of Adult Ulcerative Colitis Patients With 10-Years Follow-up
    Odes, Selwyn H.
    Vardi, Hillel
    Greenberg, Dan
    Friger, Michael
    Stockbrugger, Reinhold W.
    O'Morain, Colm A.
    Tsianos, Epameinondas V.
    Politi, Patrizia
    Clofent, Juan
    Moum, Bjorn
    Freitas, Joao
    Langholz, Ebbe
    Munkholm, Pia S.
    GASTROENTEROLOGY, 2012, 142 (05) : S256 - S256
12345